drugset / Trial / NCT00142298

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

NCT00142298

NaSingle-groupOpen-labelTreatment

Summary

This trial is being conducted as an open-label, extended-term study for patients with chronic hepatitis B who have previously completed an Idenix-sponsored trial with telbivudine.

Timeline

Start
2005-03
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Telbivudine Small molecule 600 mg Oral